A Novel Liver-Specific Fibrosis Biomarker, Pro-C18l, Can Predict Response To Antifibrotic Treatment, With A Peroxisome Proliferator Activated Receptor -Y Agonist, In Patients With Chronic Hepatitis C
JOURNAL OF HEPATOLOGY(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要